Real-time enrollment status for this sickle cell anemia (hbss, or hbsβ-thalassemia0) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:17 PM UTC
| NCT Number | NCT07175051 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Illinois at Chicago |
| Last Updated on CT.gov | May 19, 2026 (May 19, 2026) |
As of July 13, 2026: Clinical trial NCT07175051 is currently recruiting participants. This clinical trial study for sickle cell anemia (hbss, or hbsβ-thalassemia0) is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Illinois at Chicago. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07175051 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07175051 was last updated May 19, 2026 (May 19, 2026). HelloStudys verifies this status automatically.